lung disease
Breakthrough in EGFR-Mutated NSCLC: Rybrevant Plus Lazcluze Extends Overall Survival
The bispecific antibody Rybrevant plus Lazcluze significantly extended overall survival in patients with locally ...
MARCH 16, 2025
Rigel Pharmaceuticals Acquires U.S. Rights to Gavreto
Rigel Pharmaceuticals announced that it has entered into a definitive agreement to acquire the U.S. rights to ...
MAY 20, 2024
New Rx Option Breathes Some Life Into MAC Lung Disease
For the treatment of refractory MAC lung disease, Arikayce, first approved by the FDA in 2018, remains effective in ...
MAY 15, 2023
More Questions Than Answers as Vaping-Related Lung Cases, Deaths Increase
Any health care provider who sees a patient with symptoms after vaping should report the case, the CDC said.
SEPTEMBER 26, 2019
Ofev Approved for Interstitial Lung Disease
The FDA approved nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals Inc.) capsules to slow the rate of decline ...
SEPTEMBER 16, 2019
Still No Known Cause for Respiratory Disease Associated With Vaping
In reports issued today, the CDC and FDA rule out bacterial or fungal infections, with the focus now on testing of ...
SEPTEMBER 6, 2019
